Applications of Artificial Intelligence and Machine Learning in Prediabetes: A Scoping Review

被引:0
作者
Lalani, Benjamin [1 ]
Herur, Rohan [1 ]
Zade, Daniel [1 ]
Collins, Grace [1 ]
Dishong, Devin M. [1 ]
Mehta, Setu [1 ]
Shim, Jalene [1 ]
Valdez, Yllka [1 ]
Mathioudakis, Nestoras [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Div Endocrinol Diabet & Metab, 1830 East Monument St,Suite 333, Baltimore, MD 21287 USA
基金
美国国家卫生研究院;
关键词
artificial intelligence; diabetes; lifestyle intervention; machine learning; impaired glucose tolerance; prediabetes; IMPAIRED FASTING GLUCOSE; PREDICTION; RISK; PREVENTION; PROGRESSION; DIAGNOSIS; SUPPORT; INTERVENTIONS; PREVALENCE; DISEASE;
D O I
10.1177/19322968251351995
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Prediabetes is a prevalent condition in which early detection and lifestyle interventions can prevent or delay progression to diabetes. Artificial intelligence (AI) and machine learning (ML) offer enhanced tools for diagnosis, risk stratification, and scalable delivery of lifestyle interventions. This review synthesizes current applications of AI/ML in patients with prediabetes.Methods: We conducted a scoping review using PubMed, EMBASE, and Web of Science (through May 2025) to identify original studies applying AI/ML to prediabetes prediction or management. Population-level forecasting and models combining prediabetes with other conditions were excluded. Data were extracted via structured REDCap instruments and validated through secondary review. Descriptive statistics summarized findings.Results: Of 2072 records screened, 149 studies met criteria: 118 prediction model studies, 20 intervention studies, and 11 miscellaneous. Machine learning models primarily targeted prediction of prediabetes, progression to diabetes, diabetic complications, and glucose metrics. Overall model performance was favorable (mean C-statistic 0.81), with random forests, neural networks, and support vector machines showing better performance. Only 20 studies reported external validation, few compared ML to standard risk tools, and data/code availability was limited. Six AI-based diabetes prevention programs showed positive clinical outcomes, though randomized controlled trial (RCT) evidence was limited. Three personalized nutrition interventions showed mixed efficacy.Conclusion: Most AI/ML research in prediabetes focused on predictive modeling, which shows promise but limited translation to real-world settings. Artificial intelligence-based interventions may scale behavioral change support but need further evaluation versus standard care. Future efforts should prioritize external validation, assess added value over standard tools, and address barriers to integration into care.
引用
收藏
页数:18
相关论文
共 177 条
[81]   An Electronic Health Record-Compatible Model to Predict Personalized Treatment Effects From the Diabetes Prevention Program: A Cross-Evidence Synthesis Approach Using Clinical Trial and Real-World Data [J].
Kent, David M. ;
Nelson, Jason ;
Pittas, Anastassios ;
Colangelo, Francis ;
Koenig, Carolyn ;
van Klaveren, David ;
Ciemins, Elizabeth ;
Cuddeback, John .
MAYO CLINIC PROCEEDINGS, 2022, 97 (04) :703-715
[82]   Breath biomarkers of insulin resistance in pre-diabetic Hispanic adolescents with obesity [J].
Khan, Mohammad S. ;
Cuda, Suzanne ;
Karere, Genesio M. ;
Cox, Laura A. ;
Bishop, Andrew C. .
SCIENTIFIC REPORTS, 2022, 12 (01)
[83]   A randomized clinical trial comparing low-fat with precision nutrition-based diets for weight loss: impact on glycemic variability and HbA1c [J].
Kharmats, Anna Y. ;
Popp, Collin ;
Hu, Lu ;
Berube, Lauren ;
Curran, Margaret ;
Wang, Chan ;
Pompeii, Mary Lou ;
Li, Huilin ;
Bergman, Michael ;
St-Jules, David E. ;
Segal, Eran ;
Schoenthaler, Antoinette ;
Williams, Natasha ;
Schmidt, Ann Marie ;
Barua, Souptik ;
Sevick, Mary Ann .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2023, 118 (02) :443-451
[84]   Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin [J].
Knowler, WC ;
Barrett-Connor, E ;
Fowler, SE ;
Hamman, RF ;
Lachin, JM ;
Walker, EA ;
Nathan, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (06) :393-403
[85]   Harnessing machine learning models for non-invasive pre-diabetes screening in children and adolescents [J].
Kushwaha, Savitesh ;
Srivastava, Rachana ;
Jain, Rachita ;
Sagar, Vivek ;
Aggarwal, Arun Kumar ;
Bhadada, Sanjay Kumar ;
Khanna, Poonam .
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2022, 226
[86]   Longitudinal artificial intelligence-based deep learning models for diagnosis and prediction of the future occurrence of polyneuropathy in diabetes and prediabetes [J].
Lai, Yun-Ru ;
Chiu, Wen -Chan ;
Huang, Chih-Cheng ;
Cheng, Ben-Chung ;
Kung, Chia -Te ;
Lin, Ting Yin ;
Chiang, Hui Ching ;
Tsai, Chia -Jung ;
Kung, Chien-Feng ;
Lu, Cheng-Hsien .
NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY, 2024, 54 (04)
[87]   Consumer-oriented review of digital diabetes prevention programs: insights from the CDC's diabetes prevention recognition program [J].
Lalani, Benjamin ;
Shim, Jalene ;
Vadini, Vidhu ;
Valdez, Yllka ;
Zade, Daniel ;
Mathioudakis, Nestoras .
FRONTIERS IN CLINICAL DIABETES AND HEALTHCARE, 2025, 6
[88]   Net Reclassification Improvement: Computation, Interpretation, and Controversies [J].
Leening, Maarten J. G. ;
Vedder, Moniek M. ;
Witteman, Jacqueline C. M. ;
Pencina, Michael J. ;
Steyerberg, Ewout W. .
ANNALS OF INTERNAL MEDICINE, 2014, 160 (02) :122-+
[89]   Nuclear magnetic resonance-based metabolomics with machine learning for predicting progression from prediabetes to diabetes [J].
Li, Jiang ;
Yu, Yuefeng ;
Sun, Ying ;
Fu, Yanqi ;
Shen, Wenqi ;
Cai, Lingli ;
Tan, Xiao ;
Cai, Yan ;
Wang, Ningjian ;
Lu, Yingli ;
Wang, Bin .
ELIFE, 2024, 13
[90]   Non-invasive Monitoring of Three Glucose Ranges Based On ECG By Using DBSCAN-CNN [J].
Li, Jingzhen ;
Tobore, Igbe ;
Liu, Yuhang ;
Kandwal, Abhishek ;
Wang, Lei ;
Nie, Zedong .
IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS, 2021, 25 (09) :3340-3350